Physician profile
King Kim
NPI 1639358211
$1,145.18
in general payments reported to CMS, 2019-2025
11 companies · $82.88 in 2025
The $82.88 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $185 · 2021: $108 · 2022: $198 · 2023: $184 · 2024: $271 · 2025: $82.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $410.82 | 2020-2023 | Trumatch |
| Zimvie INC. | $345.24 | 2023-2025 | |
| Biohorizons Implant Systems INC. | $104.15 | 2019-2022 | |
| Geistlich Pharma, North America, INC. | $72.03 | 2020-2024 | Geistlich Bio-Gide |
| Zimmer Biomet Holdings, INC. | $58.66 | 2019 | |
| Highridge Medical LLC | $55.65 | 2024 | Biomet Ebi Bone Healing System |
| Galderma Laboratories, L.P. | $48.21 | 2019-2022 | |
| Nobel Biocare USA | $13.16 | 2021 | |
| Stryker Corporation | $12.99 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.35 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw King Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.